T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Under Armour Class C
UA
$2.25B
| $363K | ﹤0.01% |
47,907
-253,149
| -84% | -$2.85M |
|
|
NEUE
2352
DELISTED
NeueHealth
NEUE
| $363K | ﹤0.01% |
2,493
-61
| -2% | -$8.88K |
|
2353
Universal Electronics
UEIC
$66.6M
| $361K | ﹤0.01% |
14,104
+96
| +0.7% | +$2.69K |
|
2354
First Commonwealth Financial
FCF
$2.19B
| $360K | ﹤0.01% |
26,842
+449
| +2% | +$6.22K |
|
|
OLP
2355
One Liberty Properties
OLP
$537M
| $360K | ﹤0.01% |
13,867
+123
| +0.9% | +$3.41K |
|
|
ZIMV
2356
DELISTED
ZimVie
ZIMV
| $360K | ﹤0.01% |
22,508
-815,936
| -97% | -$18M |
|
|
CBAY
2357
DELISTED
Cymabay Therapeutics
CBAY
| $360K | ﹤0.01% |
122,200
+12,077
| +11% | +$28.8K |
|
2358
Cars.com
CARS
$672M
| $359K | ﹤0.01% |
38,055
+12,600
| +49% | +$136K |
|
2359
Cimpress
CMPR
$2.37B
| $358K | ﹤0.01% |
9,207
+698
| +8% | +$34.1K |
|
2360
Pitney Bowes
PBI
$2.28B
| $358K | ﹤0.01% |
98,936
-3,904
| -4% | -$17.8K |
|
|
SHYF
2361
DELISTED
The Shyft Group
SHYF
| $358K | ﹤0.01% |
19,255
+218
| +1% | +$5.34K |
|
|
ARR
2362
Armour Residential REIT
ARR
$2.37B
| $357K | ﹤0.01% |
10,138
+343
| +4% | +$12.7K |
|
2363
Gorman-Rupp
GRC
$2.11B
| $357K | ﹤0.01% |
12,616
+3,818
| +43% | +$119K |
|
|
TRTX
2364
TPG RE Finance Trust
TRTX
$616M
| $357K | ﹤0.01% |
39,577
+1,139
| +3% | +$11.9K |
|
|
CANO
2365
DELISTED
Cano Health, Inc.
CANO
| $356K | ﹤0.01% |
812
+311
| +62% | +$162K |
|
2366
The Greenbrier Companies
GBX
$1.42B
| $354K | ﹤0.01% |
9,848
+151
| +2% | +$6.3K |
|
2367
Energy Recovery
ERII
$399M
| $352K | ﹤0.01% |
18,125
+1,595
| +10% | +$30.9K |
|
2368
Stewart Information Services
STC
$2.07B
| $351K | ﹤0.01% |
7,057
+248
| +4% | +$13.3K |
|
2369
LendingTree
TREE
$461M
| $351K | ﹤0.01% |
8,007
+1,462
| +22% | +$108K |
|
|
TRUE
2370
DELISTED
TrueCar
TRUE
| $351K | ﹤0.01% |
135,557
+5,238
| +4% | +$17.4K |
|
2371
Century Aluminum
CENX
$4.59B
| $350K | ﹤0.01% |
47,504
+8,778
| +23% | +$136K |
|
2372
8x8 Inc
EGHT
$303M
| $346K | ﹤0.01% |
67,209
+20,328
| +43% | +$170K |
|
|
DX
2373
Dynex Capital
DX
$3.23B
| $345K | ﹤0.01% |
21,697
+168
| +0.8% | +$2.67K |
|
|
AAN
2374
DELISTED
The Aaron's Company Inc
AAN
| $345K | ﹤0.01% |
23,703
+133
| +0.6% | +$2.54K |
|
2375
Atara Biotherapeutics
ATRA
$76.7M
| $344K | ﹤0.01% |
1,765
+618
| +54% | +$101K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.